ZSAN

Zosano Pharma (ZSAN)

Zosano Pharma Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ZSAN

<< 이전 1 2 3 4 5 6 7 8 9 10 11 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2021/12/10	08:35	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2021/12/01	06:08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2021/11/30	11:45	GlobeNewswire Inc.	Zosano Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2021/11/25	07:54	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2021/11/17	22:03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2021/11/17	22:00	GlobeNewswire Inc.	Zosano Pharma Announces the Successful Formulation of a COVID-19 Vaccine Candidate on its Microneedle Patch System	NASDAQ:ZSAN	Zosano Pharma Corporation
2021/11/11	06:34	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ZSAN	Zosano Pharma Corporation
2021/11/11	06:10	GlobeNewswire Inc.	Zosano Pharma Reports Third Quarter 2021 Financial Results	NASDAQ:ZSAN	Zosano Pharma Corporation
2021/10/30	06:14	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2021/10/07	05:22	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2021/10/04	21:10	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2021/10/04	21:00	GlobeNewswire Inc.	Zosano Pharma Granted Type C Meeting with FDA Regarding NDA Resubmission for M207 Following Preliminary Top-Line Pharmacokinetic Study Results	NASDAQ:ZSAN	Zosano Pharma Corporation
2021/09/03	05:30	GlobeNewswire Inc.	Zosano Pharma to Present at the H.C. Wainwright Virtual Global Investment Conference	NASDAQ:ZSAN	Zosano Pharma Corporation
2021/08/11	05:05	GlobeNewswire Inc.	Zosano Pharma Reports Second Quarter 2021 Financial Results	NASDAQ:ZSAN	Zosano Pharma Corporation
2021/08/11	05:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2021/07/20	21:30	GlobeNewswire Inc.	Zosano Pharma Announces Issuance of U.S. Patent for Method of Rapidly Achieving Therapeutic Levels with M207 for the Acute Tr...	NASDAQ:ZSAN	Zosano Pharma Corporation
2021/07/15	19:30	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ZSAN	Zosano Pharma Corporation
2021/07/03	06:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2021/07/03	06:07	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:ZSAN	Zosano Pharma Corporation
2021/06/29	05:17	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:ZSAN	Zosano Pharma Corporation
2021/06/22	05:09	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ZSAN	Zosano Pharma Corporation
2021/06/22	05:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2021/06/11	05:09	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2021/06/08	07:44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2021/06/08	07:44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2021/06/02	05:20	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2021/05/27	05:05	GlobeNewswire Inc.	Zosano Pharma Announces Publication of Clinical Data Regarding the Long-term use of Qtrypta™ for the Treatment of Acute Mig...	NASDAQ:ZSAN	Zosano Pharma Corporation
2021/05/26	07:30	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2021/05/26	07:11	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ZSAN	Zosano Pharma Corporation
2021/05/26	05:13	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation